论文部分内容阅读
目的:对比分析对慢性尿毒症病人进行高通量血液透析和常规血液透析治疗的临床疗效。方法:将120例已被确诊为慢性尿毒症的患者随机分成两组,每组各60例,一组为对照组另一组则为试验组。对照组:采用常规血液透析(HD)治疗。试验组:对患者采取高通量血液透析(HFHD)治疗并在该治疗结束后,比较两组疗效。结果:试验组HFHD疗效高于对照组HD疗效,各项指标的下降率差异明显,具备统计学意义。结论:对慢性尿毒症患者采用高通量血液透析(HFHD)治疗明显有利于缓解患者的症状,提高治疗效果。
Objective: To compare the clinical efficacy of high-throughput hemodialysis and routine hemodialysis in patients with chronic uremia. Methods: One hundred and twenty patients who had been diagnosed as chronic uremia were randomly divided into two groups, 60 cases in each group. One group was control group and the other group was test group. Control group: conventional hemodialysis (HD) treatment. Trial group: Patients were treated with high-throughput hemodialysis (HFHD) and after the treatment was completed, the efficacy of the two groups was compared. Results: The efficacy of HFHD in the experimental group was higher than that of the control group, and the rate of decrease of each index was significantly different with statistical significance. Conclusion: The use of high-throughput hemodialysis (HFHD) in patients with chronic uremia significantly relieves the symptoms and improves the therapeutic effect.